Cas:1178504-57-8 4-Chloro-5-ethyl-2,6-dimethylpyrimidine manufacturer & supplier

We serve Chemical Name:4-Chloro-5-ethyl-2,6-dimethylpyrimidine CAS:1178504-57-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Chloro-5-ethyl-2,6-dimethylpyrimidine

Chemical Name:4-Chloro-5-ethyl-2,6-dimethylpyrimidine
CAS.NO:1178504-57-8
Synonyms:5-chloro-4-ethyl-1H-imidazole-2-carboxylic acid
Molecular Formula:C8H11ClN2
Molecular Weight:170.63900
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:25.78000
Exact Mass:170.06100
LogP:2.30920

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-chloro-4-ethyl-1H-imidazole-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-chloro-4-ethyl-1H-imidazole-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-chloro-4-ethyl-1H-imidazole-2-carboxylic acid Use and application,5-chloro-4-ethyl-1H-imidazole-2-carboxylic acid technical grade,usp/ep/jp grade.


Related News: The US-based study is evaluating the effect of ensifentrine on key outcomes in patients hospitalised with COVID-19, including facilitation of recovery from the viral infection, clinical status improvement and reduction in supplemental oxygen use and progression to mechanical ventilation. vinyliodosilane radical anion manufacturers Global Empowerment Mission, in phase three of the rehabilitation efforts for those who lost everything is partnering with The Shul of Bal Harbour, and funding partners EZS Events, Ygrene, and Hatzalah of South Florida to provide aid in the form of first and last month payments as well as security deposits on annual leases. O,O’-Trimethylen-bis-(phosphorsaeuredibenzylester) suppliers The outlay will be used to grow Takeda’s portfolio of treatments and boost capacity to manufacture additional products for the rare disease community, Stephen Hatke, Takeda’s Thousand Oaks site head, said in a YouTube video about the expansion. The company didn’t name the specific products it plans to make there. 1-(2,6-Di-tert-butyl-phenoxy)-3-phenoxy-propan-2-ol vendor & factory.